Post-hoc analysis of variables that showed statistical significance observing the levels of depression, Bonferroni test
| Variable 1 (V1) | Variable 2 (V2) | Mean Difference (V1-V2) | Sig. (Adjusted p values) | 95% CI | |
|---|---|---|---|---|---|
| Lower bound | Upper bound | ||||
| MR thorax | MR upper/lower limb | 1.79 | 0.046* | 0.02 | 3.55 |
| MR pelvis | MR vertebral column | 0.58 | 0.009* | 0.10 | 1.06 |
| MR pelvis | MR upper/lower limb | 0.71 | 0.007* | 0.14 | 1.28 |
| Widow | Single | 0.95 | 0.001* | 0.39 | 1.52 |
| Widow | Married | 0.98 | 0.000* | 0.47 | 1.48 |
| Widow | Divorced | 0.93 | 0.001* | 0.36 | 1.50 |
| Oncological | Orthopaedic | 0.39 | 0.011* | 0.10 | 1.26 |
| Oncological | Neurological | 0.47 | 0.002* | 0.18 | 1.18 |
Impact of depressive levels on Sociodemographic characteristics of study participants done by chi-square test
| Descriptive statistics | Depressive symptoms | Monte Carlo Sig. 2 tailed | |||||
|---|---|---|---|---|---|---|---|
| Variables | Frequency | Percentage | No symptoms | Weak symptoms | Weak to moderate | Pearson X2 value | Significance CI (lower and upper bound) |
| Gender | |||||||
| Male | 61 | 51.7 | 38 | 21 | 2 | 1.623 | 0.529 (0.516 – 0.542) |
| 62.3% | 34.4% | 3.3% | |||||
| Female | 57 | 48.3 | 29 | 25 | 3 | ||
| 50.9% | 43.9% | 5.3% | |||||
| Age groups | |||||||
| 18–24 | 7 | 5.9 | 5 | 1 | 1 | 15.140 | 0.124 (0.116 – 0.133) |
| 71.4% | 14.3% | 14.3% | |||||
| 25–34 | 12 | 10.2 | 7 | 4 | 1 | ||
| 58.3% | 33.3% | 8.3% | |||||
| 35–44 | 17 | 14.4 | 12 | 5 | 0 | ||
| 70.6% | 29.4% | 0.0% | |||||
| 45–54 | 22 | 18.6 | 15 | 7 | 0 | ||
| 68.2% | 31.8% | 0.0% | |||||
| 55–64 | 31 | 26.3 | 19 | 11 | `1 | ||
| 61.3% | 35.5% | 3.2% | |||||
| 65+ | 29 | 24.6 | 9 | 18 | 2 | ||
| 31.0% | 62.1% | 6.9% | |||||
| Education | |||||||
| Elementary | 3 | 2.5 | 1 | 1 | 1 | 15.368 | 0.122 (0.114 – 0.131) |
| 33.3% | 33.3% | 33.3% | |||||
| High school | 63 | 53.4 | 33 | 27 | 3 | ||
| 52.4% | 42.9% | 4.8% | |||||
| Higher school | 24 | 20.3 | 14 | 10 | 0 | ||
| 58.3% | 41.7% | 0.0% | |||||
| Faculty | 18 | 15.3 | 12 | 6 | 0 | ||
| 66.7% | 33.3% | 0.0% | |||||
| Master | 6 | 5.1 | 4 | 2 | 0 | ||
| 66.7% | 33.3% | 0.0% | |||||
| PhD | 4 | 3.4 | 3 | 0 | 1 | ||
| 75.0% | 0.0% | 25.0% | |||||
| Marital status | |||||||
| Not married | 20 | 16.9 | 13 | 5 | 2 | 31.762 | 0.000* (0.000 – 0.000) |
| 65.0% | 25.0% | 10.0% | |||||
| Married | 70 | 59.3 | 43 | 27 | 0 | ||
| 61.4% | 38.6% | 0.0% | |||||
| Divorced | 19 | 16.1 | 11 | 8 | 0 | ||
| 57.9% | 42.1% | 0.0% | |||||
| Widow | 9 | 7.6 | 0 | 6 | 3 | ||
| 0.0% | 66.7% | 33.3% | |||||
Impact of depressive levels on factors related to the radiology diagnostic procedures of study participants done by chi-square test
| Descriptive statistics | Depressive symptoms | Monte Carlo Sig. 2 tailed | |||||
|---|---|---|---|---|---|---|---|
| Variables | Frequency | Percentage | No symptoms | Weak symptoms | Weak to moderate | Pearson X2 value | Significance CI (lower and upper bound) |
| Time running scans | |||||||
| First time | 60 | 50.8 | 27 | 29 | 4 | 7.421 | 0.016* (0.013 – 0.020) |
| 45.0% | 48.3% | 6.7% | |||||
| Second time | 58 | 49.2 | 40 | 17 | 1 | ||
| 69.0% | 29.3% | 1.7% | |||||
| Type of MRI scan | |||||||
| Head | 23 | 19.5 | 15 | 8 | 0 | 44.941 | 0.002* (0.001 – 0.003) |
| 65.2% | 34.8% | 0.0% | |||||
| Neck | 5 | 4.2 | 4 | 1 | 0 | ||
| 80.0% | 20.0% | 0.0% | |||||
| Thorax | 1 | .8 | 0 | 0 | 1 | ||
| 0.0% | 0.0% | 100.0% | |||||
| Abdomen | 12 | 10.2 | 7 | 5 | 0 | ||
| 58.3% | 41.7% | 0.0% | |||||
| Pelvis | 27 | 22.9 | 6 | 18 | 3 | ||
| 22.2% | 66.7% | 11.1% | |||||
| Vertebral column | 31 | 26.3 | 21 | 9 | 1 | ||
| 67.7% | 29.0% | 3.2% | |||||
| Upper/lower limbs | 15 | 12.7 | 12 | 3 | 0 | ||
| 80.0% | 20.0% | 0.0% | |||||
| Breast | 4 | 3.4 | 2 | 2 | 0 | ||
| 50.0% | 50.0% | 0.0% | |||||
| Duration of waiting | |||||||
| 1–15 days | 3 | 2.5 | 1 | 1 | 1 | 24.992 | 0.018* (0.015 – 0.022) |
| 33.3% | 33.3% | 33.3% | |||||
| 16–30 days | 9 | 7.6 | 6 | 3 | 0 | ||
| 66.7% | 33.3% | 0.0% | |||||
| 1–3 months | 28 | 23.7 | 9 | 19 | 0 | ||
| 32.1% | 67.9% | 0.0% | |||||
| 3–6 months | 34 | 28.8 | 21 | 11 | 2 | ||
| 61.8% | 32.4% | 5.9% | |||||
| 6–9 months | 28 | 23.7 | 19 | 8 | 1 | ||
| 67.9% | 28.6% | 3.6% | |||||
| 9–12 months | 9 | 7.6 | 8 | 1 | 0 | ||
| 88.9% | 11.1% | 0.0% | |||||
| 1+ year | 7 | 5.9 | 3 | 3 | 1 | ||
| 42.9% | 42.9% | 14.3% | |||||
| Disease type | |||||||
| cardiovascular | 2 | 1.7 | 2 | 0 | 0 | 39.009 | 0.006* (0.004 – 0.008) |
| 100.0% | 0.0% | 0.0% | |||||
| endocrinological | 8 | 6.8 | 3 | 5 | 0 | ||
| 37.5% | 62.5% | 0.0% | |||||
| urological | 7 | 5.9 | 2 | 4 | 1 | ||
| 28.6% | 57.1% | 14.3% | |||||
| rheumatological | 4 | 3.4 | 4 | 0 | 0 | ||
| 100.0% | 0.0% | 0.0% | |||||
| gastroenterological | 9 | 7.6 | 4 | 5 | 0 | ||
| 44.4% | 55.6% | 0.0% | |||||
| oncological | 23 | 19.5 | 4 | 17 | 2 | ||
| 17.4% | 73.9% | 8.7% | |||||
| orthopedic | 18 | 15.3 | 14 | 3 | 1 | ||
| 77.8% | 16.7% | 5.6% | |||||
| neurological | 36 | 30.5 | 29 | 7 | 0 | ||
| 80.6% | 19.4% | 0.0% | |||||
| gynecological | 11 | 9.3 | 5 | 5 | 1 | ||
| 45.5% | 45.5% | 9.1% | |||||